ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $409,045 | -7.3% | 4,653 | -7.1% | 0.00% | 0.0% |
Q2 2023 | $441,229 | -30.8% | 5,006 | -15.8% | 0.00% | 0.0% |
Q1 2023 | $637,423 | -18.6% | 5,945 | -7.3% | 0.00% | 0.0% |
Q4 2022 | $783,098 | +33.6% | 6,412 | +12.9% | 0.00% | 0.0% |
Q3 2022 | $586,000 | +46.9% | 5,679 | +32.2% | 0.00% | 0.0% |
Q2 2022 | $399,000 | +17.0% | 4,295 | +48.0% | 0.00% | – |
Q1 2022 | $341,000 | -68.4% | 2,902 | -63.8% | 0.00% | -100.0% |
Q4 2021 | $1,080,000 | -20.6% | 8,026 | -6.0% | 0.00% | -50.0% |
Q3 2021 | $1,360,000 | +15.0% | 8,535 | -5.1% | 0.00% | 0.0% |
Q2 2021 | $1,183,000 | -5.0% | 8,990 | -6.9% | 0.00% | 0.0% |
Q1 2021 | $1,245,000 | -17.5% | 9,660 | +6.7% | 0.00% | -33.3% |
Q4 2020 | $1,509,000 | +13.5% | 9,050 | +5.1% | 0.00% | 0.0% |
Q3 2020 | $1,329,000 | +14.8% | 8,612 | +10.0% | 0.00% | 0.0% |
Q2 2020 | $1,158,000 | +27.7% | 7,829 | -2.8% | 0.00% | 0.0% |
Q1 2020 | $907,000 | -21.5% | 8,053 | -3.0% | 0.00% | 0.0% |
Q4 2019 | $1,155,000 | +35.9% | 8,302 | -5.9% | 0.00% | +50.0% |
Q3 2019 | $850,000 | -2.5% | 8,822 | +16.6% | 0.00% | 0.0% |
Q2 2019 | $872,000 | – | 7,569 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |